Holdings
ARK Genomic Revolution ETF
As of Jul 31, 2026, ARK Genomic Revolution ETF reported 30 positions worth US$1.49B. Largest: 10x Genomics, Inc., Twist Bioscience Corporation and Tempus Ai, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| 10x Genomics, Inc. | 3.09M | US$146M | −138K | Jul 31, 2026 |
| Twist Bioscience Corporation | 1.31M | US$120M | −586K | Jul 31, 2026 |
| Tempus Ai, Inc. | 2.33M | US$102M | +231K | Jul 31, 2026 |
| Crispr Therapeutics Ag | 2.04M | US$97.9M | −64,167 | Jul 31, 2026 |
| Personalis, Inc. | 6.73M | US$85.3M | −1.28M | Jul 31, 2026 |
| Absci Corporation | 10.3M | US$80M | −1.59M | Jul 31, 2026 |
| Guardant Health, Inc. | 456K | US$73.8M | −40,115 | Jul 31, 2026 |
| Illumina, Inc. | 360K | US$73.8M | −33,034 | Jul 31, 2026 |
| Eli Lilly And Company | 63,502 | US$73M | +50,931 | Jul 31, 2026 |
| Caredx, Inc. | 1.53M | US$66.9M | −478K | Jul 31, 2026 |